Tarveda Therapeutics, Inc. — Form D

Tarveda Therapeutics, Inc. of WATERTOWN, MA, a company, filed a Form D exempt-offering notice with the SEC on 2021-09-27. The offering totals $6.0M, of which $6.0M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (46)

Showing 25 of 46 people.

NameRoleLocation
Dennis AusielloDirectorSan Jose, CA
Nilesh KumarDirectorWatertown, MA
Guido MagniDirectorWatertown, MA
Michael MetzgerDirectorWatertown, MA
Brian RobertsDirectorNew York, NY
Aymeric SallinDirectorSanta Clara, CA
Brian RobertsExecutive OfficerNew York, NY
James BarrettDirectorRichmond, VA
Andrew FromkinDirectorNew York, NY
Andrew FromkinExecutive OfficerNew York, NY
Aymeric S SallinDirectorGaithersburg, MD
Peter Barton HuttDirectorSalt Lake City, UT
Robert J LangerDirectorWoburn, MA
Aymeric J SallinDirectorWatertown, MA
Nilesh J KumarDirectorWatertown, MA
Guido J MagniDirectorWatertown, MA
Omid J FarokhzadDirectorWatertown, MA
Andrew J FromkinDirectorWatertown, MA
Andrew J FromkinExecutive OfficerWatertown, MA
Robert S LangerDirectorNewton, MA
Robert S LangerPromoterNewton, MA
Dennis J AusielloDirectorCambridge, MA
Omid FarokhzadDirectorBoston, MA
Omid C FarokhzadDirectorWatertown, MA
Omid C FarokhzadPromoterWatertown, MA

Other filings by this issuer (9)

FiledFormOfferingSold
2020-12-28D$15.4M$15.0M
2019-12-26D$13.6M$13.6M
2017-02-09D$30.0M$30.0M
2017-02-09D/A$38.0M$38.0M
2016-01-29D$38.0M$25.5M
2014-03-12D$1000K$1000K
2013-12-24D/A$21.0M$21.0M
2012-12-20D$21.0M$16.0M
2011-09-02D$2.8M$2.8M

More